Bulletin
Investor Alert

New York Markets Close in:

Ionis Pharmaceuticals Inc.

NAS: IONS

GO
/marketstate/country/us

Countdown to close

/zigman2/quotes/201272020/composite

$

48.41

Change

-0.63 -1.27%

Volume

Volume 901,114

Sep 29, 2020, 3:16 p.m.

Real time quotes

/zigman2/quotes/201272020/composite

Previous close

$ 49.03

$ 48.41

Change

-0.63 -1.27%

Day low

Day high

$47.86

$49.20

Open
Open: 48.84

52 week low

52 week high

$39.32

$66.22

Open

Market cap

$6.85B

Average volume

753,359

P/E ratio

59.98

Rev. per Employee

$813,669

EPS

0.81

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ions

MarketWatch News on IONS

  1. Ionis Pharmaceuticals started at hold at Benchmark

    6:41 a.m. Sept. 2, 2020

    - Tomi Kilgore

  2. Panic Takes Hold

    8:39 p.m. March 12, 2020

    - Barron's Online

  3. Ionis Pharmaceuticals started at buy with $70 stock price target at BofA Merrill Lynch

    10:39 a.m. Nov. 13, 2019

    - Tomi Kilgore

  4. Bayer to advance Ionis Pharma's clotting medicine

    7:21 a.m. Oct. 9, 2019

    - MarketWatch.com

  5. How Biotech Is Targeting RNA to Cure Diseases

    8:01 a.m. Sept. 3, 2019

    - Barron's Online

  6. Ionis Pharmaceuticals stock price target raised to $63 vs. $60 at Stifel

    7:28 a.m. May 10, 2019

    - Ciara Linnane

  7. Ionis Pharmaceuticals stock price target raised to $55 from $47 at J.P. Morgan

    9:12 a.m. March 18, 2019

    - Tomi Kilgore

  8. Ionis Pharmaceuticals stock price target raised to $55 from $47 at SVB Leerink

    9:44 a.m. March 15, 2019

    - Tomi Kilgore

  9. Ionis Pharmaceuticals outlines CEO succession plan

    7:39 p.m. Dec. 20, 2018

    - Wallace Witkowski

  10. Ionis Pharmaceuticals started at market perform with $50 stock price target at Leerink

    8:14 a.m. Nov. 29, 2018

    - Tomi Kilgore

  11. Ionis Pharmaceuticals' could receive up to $759 mln from new collaboration with Roche

    9:18 a.m. Oct. 10, 2018

    - Tomi Kilgore

  12. Ionis stock drops 13% as FDA fails to approve key drug

    7:09 a.m. Aug. 29, 2018

    - Emma Court

  13. Akcea, Ionis shares drop after disappointing FDA decision

    5:07 p.m. Aug. 27, 2018

    - Wallace Witkowski

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ions

Other News on IONS

  1. Ionis Pharmaceuticals (IONS) Received its Third Buy in a Row

    11:15 p.m. Sept. 22, 2020

    - SmarterAnalyst

  2. Alexion & Caelum Begin Studies on CAEL-101 in AL Amyloidosis

    10:09 a.m. Sept. 15, 2020

    - Zacks.com

  3. Ionis up after cardio-renal pipeline update

    1:45 p.m. Sept. 2, 2020

    - Seeking Alpha

  4. Ionis to Acquire Remaining Stake in Akcea, Stocks Rally

    10:14 a.m. Sept. 1, 2020

    - Zacks.com

  5. What Akcea Shareholders Get in the Ionis Buyout

    11:36 a.m. Aug. 31, 2020

    - 247WallSt.com

  6. Oppenheimer Issues a Buy Rating on Ionis Pharmaceuticals (IONS)

    11:55 p.m. Aug. 30, 2020

    - SmarterAnalyst

  7. New reimbursement set in Germany for Akcea's Waylivra

    7:28 a.m. Aug. 13, 2020

    - Seeking Alpha

  8. 10-Q: IONIS PHARMACEUTICALS INC

    5:20 p.m. Aug. 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Ionis Pharmaceuticals (IONS) Receives a Hold from William Blair

    2:30 p.m. Aug. 5, 2020

    - SmarterAnalyst

  10. Ionis Pharmaceuticals (IONS) Receives a Buy from Needham

    2:06 p.m. Aug. 5, 2020

    - SmarterAnalyst

  11. Loading more headlines...
/news/pressrelease/company/us/ions

Press Releases on IONS

  1. Acromegaly Market Therapeutics Analysis and Clinical Developments 2020 to 2030

    7:03 a.m. Sept. 28, 2020

    - Market Insight Reports

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.